Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma.

Saved in:
Bibliographic Details
Title: Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma.
Authors: Nasir A; Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK., Cardall A; Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK., Othman RT; College of Medicine, University of Duhok, Kurdistan, Iraq., Nicolaou N; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Lourdusamy A; Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK., Linke F; Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK., Onion D; School of Life Sciences, University of Nottingham, Nottingham, UK., Ryzhova M; Department of Neuropathology, NN Burdenko Neurosurgical Institute, Moscow, Russia., Cameron H; Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK., Valente C; Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK., Ritchie A; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Korshunov A; Cooperation Unit Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Division of Pediatric Neurooncology and Heidelberg University Hospital, Department of Pediatric Hematology and Oncology, Heidelberg, Germany., Grabowska AM; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Kerr ID; School of Life Sciences, University of Nottingham, Nottingham, UK., Coyle B; Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK.
Source: Neuro-oncology advances [Neurooncol Adv] 2021 Dec 23; Vol. 3 (1), pp. vdab155. Date of Electronic Publication: 2021 Dec 23 (Print Publication: 2021).
Publication Type: Published Erratum
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first